Average Co-Inventor Count = 6.58
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ariad Pharmaceuticals, Inc. (20 from 69 patents)
2. Cubist Pharmaceuticals, Incorporated (11 from 59 patents)
3. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
4. Ariad Gene Therapeutics, Inc. (1 from 13 patents)
5. Araid Gene Therapeutics, Inc. (1 from 1 patent)
34 patents:
1. 9394308 - Inhibiting the transient receptor potential A1 ion channel
2. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors
3. 9193729 - Inhibiting transient receptor potential ion channel TRPA1
4. 9108966 - Beta-lactamase inhibitors
5. 9090561 - Acetylenic heteroaryl compounds
6. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors
7. 9024014 - Phosphorus-containing compounds and uses thereof
8. 8969570 - Beta-lactamase inhibitors
9. 8962844 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
10. 8962843 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11. 8940897 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
12. 8933233 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
13. 8933232 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
14. 8927724 - Isoxazole beta-lactamase inhibitors
15. 8916709 - 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors